David E. Parkin

6.1k citations
95 papers · 4.5k · 2 hit papers · h-index 30

Impact in

    • Uterine Myomas and Treatments
    • Endometrial and Cervical Cancer Treatments
    • Gynecological conditions and treatments
    • Ovarian cancer diagnosis and treatment
    • Endometriosis Research and Treatment

Papers in

    • Uterine Myomas and Treatments 33
    • Endometrial and Cervical Cancer Treatments 19
    • Gynecological conditions and treatments 14
    • Endometriosis Research and Treatment 19
    • Ovarian cancer diagnosis and treatment 16

David E. Parkin

92 papers receiving 4.3k citations

David E. Parkin's Hit Papers

Phase III Randomized Trial of Docetaxel-Carboplatin Versus Paclitaxel-Carboplatin as First-line Chemotherapy for Ovarian Carcinoma 2004 · 468 citations
4680+8+16Years since publication2505007501000

Peers

David E. Parkin
Comparison fields: 5 of 109
  • Obstetrics and Gynecology 1.6k
  • Reproductive Medicine 1.8k
  • Oncology 818
  • Pathology and Forensic Medicine 277
  • Surgery 620
Replace Jan B. Vermorken with:
Jan B. Vermorken Belgium
Angeles Alvarez Secord United States
Mansoor Raza Mirza Denmark
Ángel J. Lacave Spain
D. Scott McMeekin United States
Alexander Olawaiye United States
Hyun Hoon Chung South Korea
Linda Duska United States
Antonio Casado Spain
Alexander Burges Germany
David E. Parkin relative to Jan B. Vermorken Belgium Jan B. Vermorken's profile →
Citations per field
00.5×1.5×2.1×
Jan B. Vermorken · 1×
Citations per year

Countries citing papers authored by David E. Parkin

Since Specialization
Citations

This map shows the geographic impact of David E. Parkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Parkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Parkin more than expected).

Fields of papers citing papers by David E. Parkin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Parkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Parkin. The network helps show where David E. Parkin may publish in the future.

Co-authors

The 25 scholars most cited alongside David E. Parkin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David E. Parkin Line = papers co-authored together David E. Parkin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 95 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Recurrent Epithelial Ovarian Carcinoma: A Randomized Phase III Study of Pegylated Liposomal Doxorubicin Versus Topotecan
Hit paper breakdown →
20011023
2
Phase III Randomized Trial of Docetaxel-Carboplatin Versus Paclitaxel-Carboplatin as First-line Chemotherapy for Ovarian Carcinoma
Hit paper breakdown →
2004468
3 1994216
4 2008199
5
p53 mutation is a common genetic event in ovarian carcinoma.
1993158
6 2005141
7 2010139
8 1999132
9 1996115
10 1996109
11
On behalf of the Scottish Gynaecological Cancer Trials Group. Phase III Randomized Trial of Docetaxel?Carboplatin Versus Paclitaxel?Carboplatin as First-line Chemotherapy for Ovarian Carcinoma
2004103
12 200097
13 199792
14 200188
15 200573
16 200170
17 201267
18 199661
19 199757
20 199956

About David E. Parkin

David E. Parkin is a scholar working on Obstetrics and Gynecology, Reproductive Medicine, Oncology, Surgery and Epidemiology, having authored 95 papers that have together received 4.5k indexed citations. Recurring topics across this work include Uterine Myomas and Treatments (33 papers), Endometriosis Research and Treatment (19 papers), Endometrial and Cervical Cancer Treatments (19 papers), Ovarian cancer diagnosis and treatment (16 papers), Gynecological conditions and treatments (14 papers), Cervical Cancer and HPV Research (8 papers), Cancer-related Molecular Pathways (3 papers) and Global Cancer Incidence and Screening (3 papers). The work is most often cited by research in Obstetrics and Gynecology (1.6k citations), Reproductive Medicine (1.8k citations), Oncology (818 citations), Pathology and Forensic Medicine (277 citations) and Surgery (620 citations). David E. Parkin has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Kevin Cooper, Ángel J. Lacave, Martin Gore, David Guthrie, Alan N. Gordon, Vanessa N. Harry, Fiona J. Gilbert, Scott I. Semple, Christine Bain and Adrian Grant. Their work appears in journals such as BJOG An International Journal of Obstetrics & Gynaecology, Obstetrical & Gynecological Survey, International Journal of Gynecological Cancer, British Journal of Cancer and Gynecologic Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact